Trial
NCT06005428
Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Cardurion Pharmaceuticals, Inc.
Collaborators
—
Condition
CPVT1
Intervention
CRD-4730
Why stopped
The early termination of the clinical trial is due to an internal administrative and business decision, the study is not being terminated for safety reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-27